Annexon presented new ARCHER Study findings at ASRS2026, advancing research into severe vision loss in geographic atrophy. The update extends a broader run of d

Annexon presented new ARCHER Study findings at ASRS2026, advancing research into severe vision loss in geographic atrophy. The update extends a broader run of data presentations this year as the biotech builds evidence across ophthalmology and neurology.